FEATURED

Gemtuzumab Ozogamicin May Improve Survival

First-line monotherapy with low-dose gemtuzumab ozogamicin appeared to be superior in older patients with acute myeloid leukemia.

New Simplified PCa Grading System

New grading system could make it easier to explain prognoses to patients with prostate cancer.

Financial Distress After Cancer Diagnosis

Extreme financial distress appeared to influence survival after cancer diagnosis and may be taking a greater toll on patients than previously recognized.

Smoking After Breast Cancer Diagnosis

Women who continue to smoke after being diagnosed with breast cancer are almost twice as likely as those who never smoked to die of their disease.

TG4010 Vaccine Plus Chemo Appears Effective

TG4010 immunotherapy plus first-line chemotherapy appeared to improve progression-free survival in advanced non-small cell lung cancer.

KRAS, BRAF V600, Lower Survival

Post-hoc analysis of the PETACC-8 trial tied KRAS and BRAF V600E mutations to shorter overall and disease-free survival in microsatellite stable (MSS) colon cancer.

Drug Showcase: PORTRAZZA (necitumumab)

Indicated for metastatic squamous non-small cell lung cancer.

ONA Navigation Summit 2016

Recommended stopping points for surveillance for renal cell carcinoma are oversimplified and should be replaced with a more risk-stratified approach.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Gemtuzumab Ozogamicin May Improve Overall Survival in Acute Myeloid Leukemia

Gemtuzumab Ozogamicin May Improve Overall Survival in Acute Myeloid Leukemia

First-line monotherapy with low-dose gemtuzumab ozogamicin appeared to be superior in older patients with acute myeloid leukemia.

Financial Insolvency May Be a Risk Factor for Early Mortality Among Patients With Cancer

Financial Insolvency May Be a Risk Factor for Early Mortality Among Patients With Cancer

Extreme financial distress appeared to influence survival after cancer diagnosis and may be taking a greater toll on patients than previously recognized.

Feature Articles

Experts Propose New Simplified Prostate Cancer Grading System

Experts Propose New Simplified Prostate Cancer Grading System

New grading system could make it easier to explain prognoses to patients with prostate cancer.

Elevated Imatinib Dose, Second-generation TKIs Have Superior Responses in CML

Elevated Imatinib Dose, Second-generation TKIs Have Superior Responses in CML

Complete cytogenetic response was found to be higher in patients treated with elevated doses of imatinib and second-generation TKIs.

Managing Symptoms Is Key for Patients With Metastatic Cancer Who Continue to Work

Managing Symptoms Is Key for Patients With Metastatic Cancer Who Continue to Work

Patients with metastatic cancer who continue to work may need the income or access to health insurance or simply have the desire to work, yet they face a number of hurdles.

A New Era in Treating Multiple Myeloma

A New Era in Treating Multiple Myeloma

The treatment of multiple myeloma has dramatically changed over the past year.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs